A dose-response model for refractory ceramic fibers

被引:3
|
作者
Turim, J
Brown, RC
机构
[1] Sci Int Inc, Alexandria, VA 22314 USA
[2] Toxicol Serv, Stretton, Rutland, England
关键词
D O I
10.1080/08958370390228556
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Refractory ceramic fibers (RCFs) are man-made vitreous fibers commonly used in insulation applications above 1000degreesC. Although they have been subjected to considerable toxicologic evaluation, only the pooled results from two rat inhalation studies provide data that may be suitable for performing a numerical risk assessment. Even in these inhalation studies, good evidence exists that the maximum tolerated dose (MTD) was exceeded and that pulmonary overload occurred, a condition that will cause tumors whatever the dust responsible. Indeed, a significant yield of tumors was only obtained at the highest dose tested. If these results are omitted, there is no statistically significant evidence of carcinogenicity within the RCF results. Although there is little evidence that overload-related tumors are relevant to human risk, we adopted a conservative approach to obtain the estimates of risk regardless of overload, using a biologically based model, the two-stage clonal expansion model, as well as various statistical models, including the benchmark dose model. We argue that the data favor the use of a biologically based model, which gives the best fit when the highest dose RCF exposures are omitted. Continuing with this model, we show that available data from the RCF experiment, less outliers, coupled with results from other experiments with man-made mineral fibers (MMVFs), demonstrate that all MMVFs are potentially carcinogenic, with any risk mediated by the fibers' biopersistence. Application of this "all MMVF data set" model yields a maximum likely estimate for RCF excess unit risk of 4.6 x 10(-5) (95% upper confidence limit = 9.2 x 10(-5) per fiber/ml). This implies that the risk from occupational exposure to RCFs at 1 fiber/ml for a typical working lifetime would not exceed 10(-4).
引用
收藏
页码:1103 / 1118
页数:16
相关论文
共 50 条
  • [21] DOSE-RESPONSE MODEL FOR COMBINATION ANALGESIC DRUGS
    GOLDSTEIN, DJ
    BRUNELLE, RL
    ADVANCES IN PAIN RESEARCH AND THERAPY, 1991, 18 : 125 - 136
  • [22] Duration of Exposure and the Dose-Response Model of PTSD
    Kaysen, Debra
    Rosen, Gerald
    Bowman, Marilyn
    Resick, Patricia A.
    JOURNAL OF INTERPERSONAL VIOLENCE, 2010, 25 (01) : 63 - 74
  • [23] CHARACTERIZATION OF A DEVELOPMENTAL TOXICITY DOSE-RESPONSE MODEL
    FAUSTMAN, EM
    WELLINGTON, DG
    SMITH, WP
    KIMMEL, CA
    ENVIRONMENTAL HEALTH PERSPECTIVES, 1989, 79 : 229 - 241
  • [24] SPECULATIONS ON AN EXTENDED DOSE-RESPONSE MODEL FOR CARCINOGENESIS
    CARLBORG, FW
    FOOD AND CHEMICAL TOXICOLOGY, 1982, 20 (03) : 319 - 323
  • [25] FLUORIDE DOSE-RESPONSE IN AN INTRAORAL MODEL SYSTEM
    HARLESS, JD
    HOGAN, MM
    DONLY, KJ
    WEFEL, JS
    JOURNAL OF DENTAL RESEARCH, 1994, 73 : 240 - 240
  • [26] Hypothesis testing and the choice of the dose-response model
    Oughton, D
    TOXICOLOGY LETTERS, 2006, 162 (01) : 98 - 110
  • [27] DEVELOPMENT AND APPLICATIONS OF AN EQUILIBRIUM DOSE-RESPONSE MODEL
    SCHAEFFER, DJ
    JANARDAN, KG
    KERSTER, HW
    ENVIRONMENTAL MUTAGENESIS, 1980, 2 (02): : 314 - 314
  • [28] Dose-response model for Burkholderia pseudomallei (melioidosis)
    Tamrakar, S. B.
    Haas, C. N.
    JOURNAL OF APPLIED MICROBIOLOGY, 2008, 105 (05) : 1361 - 1371
  • [29] Development of a Dose-Response Model for SARS Coronavirus
    Watanabe, Toru
    Bartrand, Timothy A.
    Weir, Mark H.
    Omura, Tatsuo
    Haas, Charles N.
    RISK ANALYSIS, 2010, 30 (07) : 1129 - 1138
  • [30] Bayesian isotonic regression dose-response model
    Li, Wen
    Fu, Haoda
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2017, 27 (05) : 824 - 833